Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

bmiMD vs TrimRx

An in-depth comparison of two leading GLP-1 Providers

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
bmiMD logo

bmiMD

9.1
★★★★4.6/5

Best for: starting below a standard dose, with microdose tiers

Visit bmiMD
VS
TrimRx logo

TrimRx

7.2
★★★3.6/5

Best for: compounded semaglutide at $179/month

Visit TrimRx

Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, bmiMD opens cheaper — $99/mo against $179, and bmiMD finishes ahead, 9.1 to 7.2. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.

Pricing

bmiMD

Compounded semaglutide injection (all doses, flat)Compounded
$99/mo
semaglutide

Ladder by plan length: 12 mo $99/mo (Total $1,188.00), 6 mo $109/mo, 3 mo $119/mo, 1 mo $129/mo. 'Same price at every dose'; provider visit + free shipping included. Verified 2026-07-14 at bmimd.com/personalized-glp-1/ and /semaglutide-injection/.

Compounded tirzepatide injection (all doses, flat)Compounded
$139/mo
tirzepatide

Ladder by plan length: 12 mo $139/mo (Total $1,668.00), 6 mo $149/mo, 3 mo $159/mo, 1 mo $179/mo. Same flat-dose model. Verified 2026-07-14 at bmimd.com/tirzepatide-injection/.

Semaglutide Microdose (new product line)Compounded
$99/mo
semaglutide

Strike-through pricing shown: $151.20 -> $99/mo (12-mo) up to $199.80 -> $129/mo (monthly), labeled 'Limited time offer'. bmimd.com/glp-1-microdose/.

Tirzepatide Microdose (new product line)Compounded
$139/mo
tirzepatide

Strike-through pricing shown: $250.20 -> $139/mo (12-mo) up to $299.70 -> $179/mo (monthly), labeled 'Limited time offer'. bmimd.com/glp-1-gip-microdose/.

TrimRx

Starting (flat across doses)Compounded
$179$135/mo
Save 25% right now
semaglutide

Homepage tier 'GLP-1 Starting at $179'; hero checkout mockup shows $299.00 list struck to $179.00/1st mo; email-capture popup offers '$120 OFF for your first order — GET YOUR FIRST MONTH AS LOW AS $135'. Multi-month bundle prices ($209/$191/$174 recorded 2026-07-10) are NO LONGER published — old public checkout 404s, plans now quiz-gated.

Starting (flat across doses)Compounded
$259/mo
tirzepatide

Homepage tier 'GLP-1 + GIP Starting at $259' (hero mockup: 'GLP-1 + GIP Medication Contains Tirzepatide') — DOWN from the $279 checkout limited offer we recorded 2026-07-10; bundle prices ($316/$299/$283) no longer published (quiz-gated).

StartingBrand-name
$1249/mo
tirzepatide (mounjaro)

'Mounjaro® Starting at $1249' homepage tile; same branded-fulfillment caveat.

StartingBrand-name
$1249/mo
tirzepatide (zepbound)

'Zepbound® Starting at $1249' homepage tile; same branded-fulfillment caveat.

StartingBrand-name
$1579/mo
semaglutide (wegovy)

'Wegovy® Starting at $1579' homepage tile; same branded-fulfillment caveat.

What’s included

bmiMD

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

TrimRx

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

bmiMD

9.1/10

Overall

TrimRx

7.2/10

Value25%

9.7A
vs
B
5.4

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

8.5A
vs
B
6.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

Features & Coverage

FeaturebmiMDTrimRx
Starting Price$99/mo$179/mo
Features2 features8 features
States Available50Not disclosed
Compounded✓ Yes✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About bmiMD

bmiMD is a medical weight loss clinic that prescribes GLP-1 medications through telehealth.

Read our full bmiMD review →

About TrimRx

Three things TrimRx does not publish: the pharmacy that compounds its drugs, the states it serves, and any LegitScript certification. Specifics sit behind an intake quiz. What is visible is a cash-pay program with tiered monthly pricing plus multi-month bundles, no insurance, selling compounded semaglutide and tirzepatide shipped monthly at no shipping cost. Licensed US providers prescribe after reviewing an online medical history. The pitch is dose continuity and stable pricing: "switch and keep your current dose, no price hikes". Compounded GLP-1s are not FDA-approved.

Read our full TrimRx review →

Pros & Cons

bmiMD

What we like

  • Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
  • Tirzepatide at $139 a month, 48% below the $267 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication, consult, shipping
  • Coverage is published for all 50 states
  • No FDA warning letter matched this operator when we searched our enforcement register

Watch-outs

  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

TrimRx

What we like

  • Semaglutide at $179 a month, within the normal band around this register's $189 median for the same drug and form
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication, consult, shipping
  • No FDA warning letter matched this operator when we searched our enforcement register

Watch-outs

  • No state list is on record here, so whether it serves your state cannot be confirmed from this page
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: bmiMD

bmiMD takes it, 9.1 against 7.2, and it is especially strong on starting below a standard dose, with microdose tiers. TrimRx is no weak second and may fit you better on compounded semaglutide at $179/month.

Choose bmiMD if…

You want starting below a standard dose, with microdose tiers and an opening price near $99 a month.

Choose TrimRx if…

You want compounded semaglutide at $179/month and an opening price near $179 a month.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.9

Oak

Semaglutide at $119/month, 37% under the register median

6.5

Direct Meds

Compounded semaglutide at $249/month

7.7

Try Ageless

Semaglutide at $119/month, 37% under the register median

bmiMD vs TrimRx: FAQ

Glossary

The words sellers use, defined. Tap any term.

Continue exploring bmiMD and TrimRx head-to-heads in the same category.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.